List of SBIR/STTR awards granted to GATEWAY BIOTECHNOLOGY, INC.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to GATEWAY BIOTECHNOLOGY, INC. in September, 2022 for $555,803.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R42AG078721-01 | Phase I | 555,803 | September 30, 2022 | |||||||
A STTR Phase I contract was awarded to GATEWAY BIOTECHNOLOGY, INC. in December, 2018 for $205,183.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41DC017108-01A1 | Phase I | 205,183 | December 1, 2018 | |||||||
A STTR Phase I contract was awarded to GATEWAY BIOTECHNOLOGY, INC. in September, 2018 for $324,572.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41DC017406-01 | Phase I | 324,572 | September 1, 2018 | |||||||
A SBIR Phase I contract was awarded to GATEWAY BIOTECHNOLOGY, INC. in August, 2018 for $224,700.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DC017418-01 | Phase I | 224,700 | August 1, 2018 | |||||||
A SBIR Phase II contract was awarded to GATEWAY BIOTECHNOLOGY, INC. in July, 2020 for $972,613.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DC018759-01 | Phase II | 972,613 | July 1, 2020 | |||||||
A STTR Phase I contract was awarded to GATEWAY BIOTECHNOLOGY, INC. in September, 2017 for $224,700.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41DC016842-01 | Phase I | 224,700 | September 21, 2017 | |||||||
A STTR Phase I contract was awarded to GATEWAY BIOTECHNOLOGY, INC. in May, 2016 for $224,701.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AT008922-01A1 | Phase I | 224,701 | May 1, 2016 | |||||||
A STTR Phase I contract was awarded to GATEWAY BIOTECHNOLOGY, INC. in July, 2017 for $224,700.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41DC016575-01 | Phase I | 224,700 | July 5, 2017 | |||||||
A SBIR Phase I contract was awarded to GATEWAY BIOTECHNOLOGY, INC. for $224,700.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DC013432-01A1 | Phase I | 224,700 | ||||||||
A STTR Phase II contract was awarded to GATEWAY BIOTECHNOLOGY, INC. in September, 2023 for $473,509.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 4R42AG078721-02 | Phase II | 473,509 | September 15, 2023 | |||||||
A SBIR Phase II contract was awarded to GATEWAY BIOTECHNOLOGY, INC. in September, 2023 for $1,299,999.0 USD from the U.S. Department of Defense and Defense Health Agency. | SBIR | HT9425-23-C-0071 | Phase II | 1,299,999 | September 18, 2023 |
